beta-alanine has been researched along with glanatec in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, M; Tanna, AP | 1 |
| Robin, AL; Schehlein, EM | 1 |
| Bonardi, A; Supuran, CT | 1 |
| Rapuano, CJ; Syed, ZA | 1 |
| Colby, KA; Kinoshita, S; Kruse, FE | 1 |
| Chen, CH; Chen, YH; Cheng, F; Cheng, HL; Chou, SH; Fu, CW; Ho, WY; Huang, YC; Hung, CL; Hwang, CS; Lin, MC; Lin, WY; Liu, CP; Lu, DW; She, MP; Tu, CM; Wang, YJ; Yang, CY | 1 |
3 review(s) available for beta-alanine and glanatec
| Article | Year |
|---|---|
Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension.
Topics: Antihypertensive Agents; Aqueous Humor; Benzoates; beta-Alanine; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Isoquinolines; Ocular Hypertension; rho-Associated Kinases; Sulfonamides; Translational Research, Biomedical | 2018 |
Rho-Associated Kinase Inhibitors: Evolving Strategies in Glaucoma Treatment.
Topics: Animals; Benzoates; beta-Alanine; Drug Therapy, Combination; Eye; Glaucoma; Humans; Intraocular Pressure; Isoquinolines; Latanoprost; Protein Kinase Inhibitors; rho-Associated Kinases; Signal Transduction; Sulfonamides | 2019 |
Rho kinase (ROCK) inhibitors in the management of corneal endothelial disease.
Topics: Benzoates; beta-Alanine; Fuchs' Endothelial Dystrophy; Humans; Isoquinolines; Protein Kinase Inhibitors; rho-Associated Kinases; Sulfonamides | 2021 |
3 other study(ies) available for beta-alanine and glanatec
| Article | Year |
|---|---|
Treatment of glaucoma and ocular hypertension using rho kinase inhibitors: patent evaluation of US2018244666 and US2018256595.
Topics: Benzoates; beta-Alanine; Glaucoma; Humans; Intraocular Pressure; Isoquinolines; Ocular Hypertension; Patents as Topic; Protein Kinase Inhibitors; rho-Associated Kinases; Sulfonamides | 2019 |
A Close Look at the Clinical Efficacy of Rho-Associated Protein Kinase Inhibitor Eye Drops for Fuchs Endothelial Corneal Dystrophy.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Administration, Ophthalmic; Benzoates; beta-Alanine; Clinical Trials as Topic; Fuchs' Endothelial Dystrophy; Humans; Isoquinolines; Ophthalmic Solutions; Protein Kinase Inhibitors; rho-Associated Kinases; Sulfonamides; Treatment Outcome | 2021 |
The Intraocular Pressure Lowering Effect of a Dual Kinase Inhibitor (ITRI-E-(S)4046) in Ocular Hypertensive Animal Models.
Topics: Animals; Benzoates; beta-Alanine; Calcium-Binding Proteins; Disease Models, Animal; Humans; Intraocular Pressure; Isoquinolines; Macaca; Male; Myosin-Light-Chain Kinase; Ocular Hypertension; Rabbits; rho-Associated Kinases; Sulfonamides; Tonometry, Ocular | 2021 |